The increasing need for effective sterile filtration in the pharmaceutical industry calls for advancements in microfiltration (MF) membrane technology that can effectively reduce fouling and preserve essential protein products. Our study highlights the crucial role of improving the hydrophilicity throughout the entire membrane, not just on the surface, to decrease both protein adsorption and fouling. We have developed a facile but effective method for producing hydrophilic porous polyethersulfone (PES) MF membranes using vapor-induced phase separation (VIPS) followed by a hydrophilic coating. By meticulously adjusting the vapor exposure time, we fabricated two specific types of symmetric membranes: a standard one with a mean pore size of 0.22 μm and another designed with slightly larger pores for the subsequent polydopamine (PDA) coating. All membranes developed in this study showed an outstanding sterilization performance (over 99.99999 % bacteria rejection) due to the absence of defects. Our comparative studies of PDA coating in both acidic and basic environments revealed that the PDA-modified membranes in a Tris-HCl buffer (pH 8.0) (PDA-b-PES2M) outperform others in performance of protein microfiltration. While the membrane modified under acidic conditions underwent a gradual degradation of PDA leading to a poor filtration performance, the PDA-b-PES2M membranes showcased remarkable anti-fouling properties, greatly minimizing the adsorption of bovine serum albumin (BSA) and simplifying the removal of adsorbed materials. Our optimized membrane has a great potential for sterile filtration applications where minimizing protein loss is crucial.
Read full abstract